Skip to content
News
Data
Podcast
Clinics
EVENTS
News
Data
Podcast
Clinics
EVENTS
Search
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Advertise
NEWSLETTER
Sign in
News
Data
Podcast
Clinics
EVENTS
News
Data
Podcast
Clinics
EVENTS
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
About
Contact
About
Contact
Advertise
nEWSLETTER
Search
Search
Sign in
Mogrify to present preclini...
MetaVia shows uric acid red...
Annovis secures patent for ...
Eisai, Linus Health launch ...
Alzheon launches second Pha...
Mogrify to present preclini...
MetaVia shows uric acid red...
Annovis secures patent for ...
Eisai, Linus Health launch ...
Alzheon launches second Pha...
Longevity investing
Longevity 2020
Longevity investing
Videos
The view from the valley
Longevity 2020
Longevity investing
Videos
Accelerating agetech
Longevity 2020
Longevity investing
Videos
The Big Picture: Covid-19 and Longevity investing
Jim Mellon, Chairman and Founder, Burnbrae Group
Longevity 2020
Longevity investing
Videos
The Juvenescence business model and future of anti-aging
Longevity 2020
Longevity investing
Videos
Global pandemics & accelerated investment in Longevity
Longevity 2020
Longevity investing
Videos
The crucial question in Longevity investing: is it repair?
Longevity 2020
Longevity investing
Videos
Genome editing: opportunity & anxiety in equal measure
Longevity 2020
Longevity investing
Videos
From science fiction to FDA submission: ectopic organoids & the commercialization of regenerative medicine
Longevity 2020
Longevity investing
Videos
How to identify new targets and indications for aging drug development
Longevity 2020
Longevity investing
Videos
Risk & reward: Longevity investments
Longevity 2020
Longevity investing
Videos
5 investment lessons from coronavirus
Longevity 2020
Longevity investing
Videos
‘Longevity investing’ Ask Me Anything
Google
Microsoft
Apple
LinkedIn
or use your email
The latest longevity science, investment, innovation and insight, delivered every morning.
First Name
(Required)
Email Address
(Required)
Contact Source
Unlock Longevity Biotech Report for FREE
$617BN - Annual global revenue by 2045
$30BN+ - Invested in under 2 years
3,036 - Therapeutics individually assessed
Access full report